Editado por: Silvia Pellitero-Rodrguez - University Hospital Germans Trias i Pujol Badalona Federico Vzquez Sanmiguel - University Hospital Germans Trias i Pujol Badalona ltima actualizacin : Octubre 2025 La molcula del pptido anlogo al glucagn tipo1 (GLP-1) ha emergido, merced a la bioingeniera bioqumica, como un elemento esencial en el desarrollo de agonistas y multiagonistas basados en su estructura para el tratamiento de la obesidad
In addition to activating the GLP-1 receptor, it also stimulates the GIP receptor, which plays a role in fat metabolism and energy balance
It is FDA-approved for managing blood sugar levels in patients with type 2 diabetes as an adjunct to dietary changes and increased physical activity
Possibly, but usually mild
These Include Pancreatitis (Inflammation of the Pancreas), Vision Changes, Hypoglycemia (Low Blood Sugar), Kidney Problems, Intense Stomach Pain, Gallbladder Issues, and Allergic Reactions
